The Benefit of Multigene Panel Testing for the Diagnosis and Management of the Genetic Epilepsies
Open Access
Abstract
With the increasing use of genetic testing in pediatric epilepsy, it is important to describe the diagnostic outcomes as they relate to clinical care. The goal of this study was to assess the diagnostic yield and impact on patient care of genetic epilepsy panel testing. We conducted a retrospective chart review of patients at the Children’s Hospital of Eastern Ontario (CHEO) who had genetic testing between the years of 2013–2020. We identified 227 patients that met criteria for inclusion. The majority of patients had their testing performed as “out-of-province” tests since province-based testing during this period was limited. The diagnostic yield for multi-gene epilepsy panel testing was 17% (39/227) and consistent with the literature. Variants of unknown significance (VUS) were reported in a significant number of undiagnosed individuals (77%; 128/163). A higher diagnostic rate was observed in patients with a younger age of onset of seizures (before one year of age; 32%; 29/90). A genetic diagnosis informed prognosis, recurrence risk counselling and expedited access to resources in all those with a diagnosis. A direct change in clinical management as a result of the molecular diagnosis was evident for 9% (20/227) of patients. The information gathered in this study provides evidence of the clinical benefits of genetic testing in epilepsy and serves as a benchmark for comparison with the current provincial Ontario Epilepsy Genetic Testing Program (OEGTP) that began in 2020.Keywords
Funding Information
- CHEO Genetics Associate’s Research Fund
This publication has 30 references indexed in Scilit:
- The Genetics of the EpilepsiesCurrent Neurology and Neuroscience Reports, 2015
- Early and effective treatment of KCNQ2 encephalopathyEpilepsia, 2015
- Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular PathologyGenetics in Medicine, 2015
- The phenotypic spectrum of SCN8A encephalopathyNeurology, 2015
- Diagnostic Yield of Clinical Next-Generation Sequencing Panels for EpilepsyJAMA Neurology, 2014
- Tuberous Sclerosis Complex Surveillance and Management: Recommendations of the 2012 International Tuberous Sclerosis Complex Consensus ConferencePediatric Neurology, 2013
- The clinical utility of an SCN1A genetic diagnosis in infantile‐onset epilepsyDevelopmental Medicine & Child Neurology, 2012
- Incidence and classification of new-onset epilepsy and epilepsy syndromes in children in Olmsted County, Minnesota from 1980 to 2004: A population-based studyEpilepsy Research, 2011
- The pharmacologic treatment of Dravet syndromeEpilepsia, 2011
- Research electronic data capture (REDCap)—A metadata-driven methodology and workflow process for providing translational research informatics supportJournal of Biomedical Informatics, 2009